SYMFI LO FDA approval date

The FDA approved SYMFI LO on 5 Feb 2018.

FDA approval date
5 Feb 2018

Drug identity has not yet been verified against registry records

Also recorded as EFAVIRENZ; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE

Included trials

No linked trials for this drug yet. Browse all trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2018-02-05DaySYMFI LOFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA208255", "applicant_as_listed_by_fda": "MYLAN", "brand_names": ["SYMFI LO"], "active_ingredients": ["EFAVIRENZ", "LAMIVUDINE", "TENOFOVIR DISOPROXIL FUMARATE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20180205", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026